Investigation of FOXM1 as a Potential New Target for Melanoma von Miyashita, Azusa, Fukushima, Satoshi, Nakahara, Satoshi, Yamashita, Junji, Tokuzumi, Aki, Aoi, Jun, Ichihara, Asako, Kanemaru, Hisashi, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma von Nakahara, Satoshi, Fukushima, Satoshi, Okada, Etsuko, Morinaga, Jun, Kubo, Yosuke, Tokuzumi, Aki, Matsumoto, Sayaka, Tsuruta-Kadohisa, Mina, Kimura, Toshihiro, Kuriyama, Haruka, Miyashita, Azusa, Kajihara, Ikko, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma von Kubo, Yosuke, Fukushima, Satoshi, Inamori, Yukiko, Tsuruta, Mina, Egashira, Sho, Yamada-Kanazawa, Saori, Nakahara, Satoshi, Tokuzumi, Aki, Miyashita, Azusa, Aoi, Jun, Kajihara, Ikko, Tomita, Yusuke, Wakamatsu, Kazumasa, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Cell division cycle-associated protein 1 as a new melanoma-associated antigen von Tokuzumi, Aki, Fukushima, Satoshi, Miyashita, Azusa, Nakahara, Satoshi, Kubo, Yosuke, Yamashita, Junji, Harada, Miho, Nakamura, Kayo, Kajihara, Ikko, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma von Kuriyama, Haruka, Fukushima, Satoshi, Kimura, Toshihiro, Kanemaru, Hisashi, Miyashita, Azusa, Okada, Etsuko, Kubo, Yosuke, Nakahara, Satoshi, Tokuzumi, Aki, Nishimura, Yuki, Kajihara, Ikko, Makino, Katsunari, Aoi, Jun, Masuguchi, Shinichi, Tsukamoto, Hirotake, Inozume, Takashi, Zhang, Rong, Nakatsura, Tetsuya, Uemura, Yasushi, Senju, Satoru, Ihn, Hironobu

Volltext

Induced pluripotent stem cell‐derived myeloid cells expressing OX40 ligand amplify antigen‐specific T cells in advanced melanoma von Kimura, Toshihiro, Fukushima, Satoshi, Okada, Etsuko, Kuriyama, Haruka, Kanemaru, Hisashi, Kadohisa‐Tsuruta, Mina, Kubo, Yosuke, Nakahara, Satoshi, Tokuzumi, Aki, Kajihara, Ikko, Makino, Katsunari, Miyashita, Azusa, Aoi, Jun, Makino, Takamitsu, Tsukamoto, Hirotake, Nishimura, Yasuharu, Inozume, Takashi, Zhang, Rong, Uemura, Yasushi, Senju, Satoru, Ihn, Hironobu

Volltext

AT-rich interaction domain-containing protein 3B has a potential to be a new stem cell marker of melanoma von Nakahara, Satoshi, Fukushima, Satoshi, Yamashita, Junji, Kubo, Yosuke, Tokuzumi, Aki, Miyashita, Azusa, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Hair shaft miRNA-221 levels as a new tumor marker of melanoma von Fukushima, Satoshi, Inada, Taisuke, Murai, Masayuki, Jinnin, Masatoshi, Miyashita, Azusa, Nakahara, Satoshi, Tokuzumi, Aki, Ihn, Hironobu

Volltext

AT-rich Interaction Domain-containing Protein 3B is a New Tumour Marker for Melanoma von Nakahara, Satoshi, Fukushima, Satoshi, Yamashita, Junji, Kubo, Yosuke, Tokuzumi, Aki, Miyashita, Azusa, Harada, Miho, Nakamura, Kayo, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Cell division cycle associated gene 1 as a new therapeutic target for melanoma von Tokuzumi, Aki, Fukushima, Satoshi, Miyashita, Azusa, Yamashita, Junji, Nakahara, Satoshi, Kubo, Yosuke, Makino, Takamitsu, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Immunotherapy against Metastatic Melanoma with Human iPS Cell-Derived Myeloid Cell Lines Producing Type I Interferons von Miyashita, Azusa, Fukushima, Satoshi, Nakahara, Satoshi, Kubo, Yosuke, Tokuzumi, Aki, Yamashita, Junji, Aoi, Jun, Haruta, Miwa, Senju, Satoru, Nishimura, Yasuharu, Jinnin, Masatoshi, Ihn, Hironobu

Volltext

Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma von Ichigozaki, Yuki, Fukushima, Satoshi, Jinnin, Masatoshi, Miyashita, Azusa, Nakahara, Satoshi, Tokuzumi, Aki, Yamashita, Junji, Kajihara, Ikko, Aoi, Jun, Masuguchi, Shinichi, Zhongzhi, Wang, Ihn, Hironobu

Volltext